GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (FRA:IG7) » Definitions » FCF Yield %

Memphasys (FRA:IG7) FCF Yield % : -29.51 (As of May. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Memphasys FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Memphasys's Trailing 12-Month Free Cash Flow is €-2.23 Mil, and Market Cap is €7.52 Mil. Therefore, Memphasys's FCF Yield % for today is -29.51%.

The historical rank and industry rank for Memphasys's FCF Yield % or its related term are showing as below:

FRA:IG7' s FCF Yield % Range Over the Past 10 Years
Min: -426.31   Med: -73.9   Max: -8.48
Current: -29.51


During the past 13 years, the highest FCF Yield % of Memphasys was -8.48%. The lowest was -426.31%. And the median was -73.90%.

FRA:IG7's FCF Yield % is ranked worse than
66.45% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs FRA:IG7: -29.51

Memphasys's FCF Margin % for the quarter that ended in Dec. 2023 was -3,981.82%.


Memphasys FCF Yield % Historical Data

The historical data trend for Memphasys's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Memphasys FCF Yield % Chart

Memphasys Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.17 -7.26 -6.37 -8.71 -39.96

Memphasys Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.82 -10.38 -19.06 -53.92 -44.27

Competitive Comparison of Memphasys's FCF Yield %

For the Biotechnology subindustry, Memphasys's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Memphasys's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Memphasys's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Memphasys's FCF Yield % falls into.



Memphasys FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Memphasys's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.001 / 5.0077
=-39.96%

Memphasys's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.876 * 2 / 3.957205
=-44.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Memphasys FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Memphasys FCF Yield % Related Terms

Thank you for viewing the detailed overview of Memphasys's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Memphasys (FRA:IG7) Business Description

Traded in Other Exchanges
Address
30 Richmond Road, Homebush, Sydney, NSW, AUS, 2140
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Memphasys (FRA:IG7) Headlines

No Headlines